| Filed On | Filing |
|---|---|
| 28 Oct 2026 |
Proxy statement: annual meeting on November 30, 2026
CEO pay $351K, up 7.9% |
| 28 Oct 2025 |
Proxy statement: annual meeting on December 1, 2025
CEO pay $325K, down 1.9% · say-on-pay vote |
| 28 Oct 2024 | Proxy statement: annual meeting on December 2, 2024 |
| 27 Oct 2023 | FORM DEF 14A |
| 27 Oct 2022 | FORM DEF 14A |
| 27 Oct 2021 | FORM DEF 14A |
| 28 Oct 2020 | FORM DEF 14A |
| 28 Oct 2019 | FORM DEF 14A |
| 29 Oct 2018 | FORM DEF 14A |
| 27 Oct 2017 | FORM DEF 14A |
| 28 Oct 2016 | FORM DEF 14A |
| 26 Oct 2015 | DEF 14A |
| 28 Oct 2014 | DEF 14A |
| 28 Oct 2013 | DEF 14A |
| 29 Oct 2012 | DEF 14A |
| 28 Oct 2011 | DEF 14A |
| 28 Oct 2010 | DEF 14A |
| 28 Oct 2009 | DEF 14A |
| 28 Oct 2008 | DEF 14A |
| 30 Oct 2007 | INTEGRATED BIOPHARMA, INC. |
Loading...
